Lalach Harvey 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed May 29, 2012
Insider Transaction Report
Form 4
Lalach Harvey
DirectorPresident CEO CFO
Transactions
- Sale
common stock
2012-05-24$0.80/sh−10,000$8,000→ 558,572 total - Sale
common stock
2012-05-29$1.05/sh−8,572$9,001→ 550,000 total
Holdings
- 200,000
stock options
Exercise: $3.50From: 2010-06-29Exp: 2015-06-29→ common stock (50,000 underlying) - 568,572
common stock
- 150,000
stock options
Exercise: $3.10From: 2008-06-03Exp: 2013-06-03→ common stock (150,000 underlying)